Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiation Safety”

979 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 979 results

Not applicableStudy completedNCT00462124
What this trial is testing

Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy

Who this might be right for
Prostate Cancer
BioProtect 7
Not applicableUnknownNCT04266327
What this trial is testing

RISI in the Treatment of Recurrent Metastatic SCC of Thoracic Inlet Lymph Nodes

Who this might be right for
BrachytherapySquamous Cell Carcinomas
Peking University Third Hospital 30
Very early researchStudy completedNCT05126927
What this trial is testing

A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors

Who this might be right for
Solid Tumor
SmartNuclide Biopharma 11
Not applicableLooking for participantsNCT06987370
What this trial is testing

SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue

Who this might be right for
Bone Metastases in Subjects With Advanced Cancer
Shandong Cancer Hospital and Institute 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07196345
What this trial is testing

TAS-102 Plus Radiotherapy in Elderly ESCC

Who this might be right for
ESCCTAS 102Radiotherapy
Qianfoshan Hospital 45
Not applicableNot Yet RecruitingNCT06348875
What this trial is testing

Clinical Evaluation of Radiation Reduction for Optimized Safety

Who this might be right for
Coronary Artery DiseaseMyocardial InfarctionCoronary Disease+3 more
Angiowave Imaging 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07397442
What this trial is testing

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III
Beijing Friendship Hospital 19
Very early researchStudy completedNCT05775601
What this trial is testing

18F-LY3950321-01 Biodistribution and Safety Study

Who this might be right for
Diagnostic Agent Adverse ReactionRadiation Exposure
Avid Radiopharmaceuticals 6
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Early research (Phase 1)Looking for participantsNCT03546829
What this trial is testing

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783153
What this trial is testing

Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients

Who this might be right for
Radiotherapy Induced DiarrheaAcute Radiation EnteritisProstate Cancer+5 more
Mansoura University 80
Testing effectiveness (Phase 2)Study completedNCT00923195
What this trial is testing

Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Cancer
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT05235269
What this trial is testing

Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis

Who this might be right for
Amyloidosis
Attralus, Inc. 33
Not applicableStudy completedNCT04540588
What this trial is testing

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Early research (Phase 1)Active Not RecruitingNCT05615142
What this trial is testing

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

Who this might be right for
NSCLCLow Dose RadiotherapyStereotactic Body Radiotherapy+1 more
Sichuan University 9
Early research (Phase 1)Looking for participantsNCT06894979
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Childhood AstrocytomaChildhood Diffuse Intrinsic Pontine GliomaChildhood Diffuse Midline Glioma+2 more
Children's Oncology Group 54
Early research (Phase 1)Active Not RecruitingNCT05678010
What this trial is testing

AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

Who this might be right for
Solid TumorMetastatic Solid TumorSolid Carcinoma+3 more
Memorial Sloan Kettering Cancer Center 54
Early research (Phase 1)Looking for participantsNCT03423628
What this trial is testing

Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Who this might be right for
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca 180
Not applicableUnknownNCT05160857
What this trial is testing

Clinical Study on the Efficacy and Safety of Hetropapa Ethanolamine Tablets in the Treatment of Thrombocytopenia Caused by Concurrent Radiotherapy and Chemotherapy in Cervical Cancer

Who this might be right for
Tumor Chemotherapy-related Thrombocytopenia
Second Hospital of Shanxi Medical University 30
Early research (Phase 1)UnknownNCT05225116
What this trial is testing

Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Who this might be right for
Hepatocellular Carcinoma
Beijing Tsinghua Chang Gung Hospital 20
Load More Results